In 2012, he released an updated version called the Altman Z - score Plus that can be used to
evaluate public and private companies, manufacturing and nonmanufacturing companies, and U.S. and non-U.S. companies.
Not exact matches
Andrew's primary responsibility at RA Capital is to
evaluate public and private investments in
companies developing drugs, medical devices, diagnostics,
and research tools, with a focus on new
company formation.
He has
evaluated, invested in
and served as a board member of numerous
companies, both
public and private,
and is familiar with a full range of corporate
and board functions.